Literature DB >> 9352254

Diphtheria immunity in Flanders.

C Matheï1, P Van Damme, P Bruynseels, H Goossens, R Vranckx, A Meheus.   

Abstract

A serological survey to determine the immunity to diphtheria in the Flemish population was conducted according to the recommendations of the World Health Organization. Immunity to diphtheria was determined on a randomised, stratified sample (1679 serum samples) from an existing serum bank (4058 serum samples) representative of the Flemish population. All age groups between 0 and 100 years were included. A tissue (Vero cell) culture toxin neutralisation assay was used to measure serum diph-theria antitoxin concentrations. The results showed that 43% of the Flemish population was protected against diphtheria (antitoxin titre, > or = 0.1 IU/ml), while 32% was susceptible (antitoxin titre, < 0.01 IU/ml); for 25%, protection was of limited duration (antitoxin titre, > or = 0.01 IU/ml and < 0.1 IU/ml). The proportion of susceptible subjects showed a significant age-related increase, with the highest values in the 35 to 44 and 45 to 54 age groups (57.9% and 55.5%, respectively). These results emphasise the need for booster immunization of adults.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9352254     DOI: 10.1007/bf01708551

Source DB:  PubMed          Journal:  Eur J Clin Microbiol Infect Dis        ISSN: 0934-9723            Impact factor:   3.267


  19 in total

1.  Molecular epidemiology of the 1984-1986 outbreak of diphtheria in Sweden.

Authors:  R Rappuoli; M Perugini; E Falsen
Journal:  N Engl J Med       Date:  1988-01-07       Impact factor: 91.245

2.  Update: diphtheria epidemic--New Independent States of the Former Soviet Union, January 1995-March 1996.

Authors: 
Journal:  MMWR Morb Mortal Wkly Rep       Date:  1996-08-16       Impact factor: 17.586

Review 3.  Current situation and control strategies for resurgence of diphtheria in newly independent states of the former Soviet Union.

Authors:  I R Hardy; S Dittmann; R W Sutter
Journal:  Lancet       Date:  1996-06-22       Impact factor: 79.321

4.  Herd immunity: basic concept and relevance to public health immunization practices.

Authors:  J P Fox; L Elveback; W Scott; L Gatewood; E Ackerman
Journal:  Am J Epidemiol       Date:  1971-09       Impact factor: 4.897

5.  Antitoxin responses in the elderly to tetanus-diphtheria (TD) immunization.

Authors:  F L Ruben; J Nagel; P Fireman
Journal:  Am J Epidemiol       Date:  1978-08       Impact factor: 4.897

6.  Micro cell culture method for determination of diphtheria toxin and antitoxin titres using VERO cells. II. Comparison with the rabbit skin method and practical application for seroepidemiological studies.

Authors:  K Miyamura; E Tajiri; A Ito; R Murata; R Kono
Journal:  J Biol Stand       Date:  1974-07

7.  The effect of Schick testing on diphtheria antitoxin status.

Authors:  B Bannister; M J Corbel
Journal:  J Infect       Date:  1991-01       Impact factor: 6.072

Review 8.  Immunization against diphtheria with special emphasis on immunization of adults.

Authors:  A M Galazka; S E Robertson
Journal:  Vaccine       Date:  1996-06       Impact factor: 3.641

9.  Serological immunity to diphtheria in Sweden in 1978 and 1984.

Authors:  B Christenson; M Böttiger
Journal:  Scand J Infect Dis       Date:  1986

10.  [Diphtheria immunity and its epidemiological significance].

Authors:  P Naumann; H J Hagedorn; R Paatz
Journal:  Dtsch Med Wochenschr       Date:  1983-07-15       Impact factor: 0.628

View more
  3 in total

1.  Response to diphtheria booster vaccination in healthy adults: vaccine trial.

Authors:  A Vellinga; P Van Damme; E Joossens; H Goossens
Journal:  BMJ       Date:  2000-01-22

Review 2.  Adult vaccination against tetanus and diphtheria: the European perspective.

Authors:  B Weinberger
Journal:  Clin Exp Immunol       Date:  2016-07-12       Impact factor: 4.330

3.  The seroepidemiology of herpes simplex virus type 1 and 2 in Europe.

Authors:  R G Pebody; N Andrews; D Brown; R Gopal; H De Melker; G François; N Gatcheva; W Hellenbrand; S Jokinen; I Klavs; M Kojouharova; T Kortbeek; B Kriz; K Prosenc; K Roubalova; P Teocharov; W Thierfelder; M Valle; P Van Damme; R Vranckx
Journal:  Sex Transm Infect       Date:  2004-06       Impact factor: 3.519

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.